Glaucoma screening and eye health study via telemedicine
Part of Brain & nervous system, Eyes & vision clinical trials.
This study tests if telemedicine can help find glaucoma and other eye problems early. It may help people who speak one of several languages and want to check their eye health from home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You speak English, Spanish, Arabic, Chinese, French, Hindi, Finnish, Albanian, Russian, or Tagalog
- You do not have significant eye pain right now
- You have not had a sudden loss of vision in the past week
- You do not have double vision all the time
- You are not pregnant
- You have not already said no to joining this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
This trial uses an AI tool to screen for glaucoma at community health centers. If you qualify, you will get a free eye check to catch glaucoma early and help researchers improve screening for high-risk groups.
This trial tests if a large language model tool can help patients perform more reliable visual field tests. It may improve detection of glaucoma progression.
This study tests whether offering eye exams at a health center helps find glaucoma early in people who are at higher risk. It may help you catch vision problems before they get worse.
This study tests a new algorithm to help screen for glaucoma in people of African descent. It aims to improve early detection and diagnosis.
This trial uses a smart computer system to help diagnose multiple eye diseases by looking at your eye scans. You may qualify if you have one of the listed eye conditions and your scans are clear enough for the AI to analyze.
Hear when a new Eye Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.